Alopecia areata trials in Poland

In Poland 7 Also abroad 44

7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Active, not recruiting
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Where
Bialystok, Bydgoszcz, Gdansk, Katowice, Kielce, Krakow, Lodz, Ostrowiec Świętokrzyski, Rzeszów, Szczecin, Warsaw, Warszawa, Wroclaw
Age
6 years to 17 years
People
595 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05723198 · EU 2022-502700-78-00
Phase 2Taking people
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Where
Cracow, Gdansk, Ostrowiec Świętokrzyski, Wroclaw
Age
18 years to 60 years
People
65 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07533006 · EU 2025-524727-41-00
Phase 3Not yet taking people in Poland
A study in young people and adults to learn about the medicine ritlecitinib for treatment of patchy hair loss, known by the medical term as moderate alopecia areata
Where
Gdansk, Katowice, Kraków, Lublin, Nowa Sol, Sosnowiec, Szczecin, Warsaw
People
90 worldwide
Run by
Pfizer Inc.
See details and how to join2026-526355-62-00
Phase 3Active, not recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Where
Gdansk, Katowice, Krakow, Lublin, Nowa Sol, Poznan, Sosnowiec, Szczecin, Warsaw, Warszawa, Wroclaw, Wrocław
Age
12 years and over
People
674 worldwide
Run by
Pfizer
See details and how to joinNCT06873945 · EU 2024-519370-40-00
Phase 3Active, not recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Where
Bialystok, Cracow, Elblag, Gdansk, Katowice, Krakow, Torun, Warsaw
Age
12 years to 63 years
People
1,500 worldwide
Run by
AbbVie
See details and how to joinNCT06012240 · EU 2023-505061-82-01
Phase 3Taking people
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Where
Bialystok, Katowice, Krakow, Łódź, Lublin, Ozarowice, Rzeszów, Warsaw, Warszawa, Wroclaw
Age
6 years to 14 years
People
140 worldwide
Run by
Pfizer
See details and how to joinNCT07029828 · EU 2024-515439-31-00
Phase 2Taking people
A Study of LAD603 in Adults With Alopecia Areata
Where
Katowice, Kielce, Krakow, Nowa Sol, Torun, Warsaw, Wroclaw
Age
18 years to 65 years
People
136 worldwide
Run by
Almirall, S.A.
See details and how to joinNCT07311564 · EU 2025-523342-27-00